secwatch.observer — SEC 8-K summary
======================================

Issuer:     Picard Medical, Inc. (PMI)
CIK:        0002030617
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001829126-26-002794
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Picard Medical FY2025 revenue $4.94M (+12.5% YoY); U.S. rev +33.5%
------------------------------------------------------------------

- Revenue $4.94M (+12.5% YoY); U.S. revenue +33.5% to 88.25% of total.
- Net loss ~$27M (incl. $14.5M non-cash); cash burn $15.67M; IPO raised $35.55M.
- Emperor TAH in preclinical; FDA Breakthrough designation possible in 2026; 2028 clinical study target.
- Manufacturing: valve assembly in-house, driver transfer to China, second source qualification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030617/000182912626002794/0001829126-26-002794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030617/000182912626002794/picardmedical_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-002794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer